BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Accounts Payable and Accrued Liabilities
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $26.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $23.16M, a 301.75% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $3.10M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$53.34M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $116.37M, a 4.84% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $66.14M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$32.24M, a 146.82% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $68.85M, a 16.66% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $59.02M, a 276.17% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $23.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $26.27M 10-Q · filed 2026-08-06 | -$27.08M derived: sum of 3 quarters · filed 2026-08-06 | $89.29M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-05 | -$50.24M derived: sum of 2 quarters · filed 2026-05-05 | $66.13M derived: sum of 3 quarters · filed 2026-05-05 | $71.89M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$53.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $63.02M derived: sum of 2 quarters · filed 2026-02-26 | $68.79M derived: sum of 3 quarters · filed 2026-08-06 | $66.14M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $116.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $122.13M derived: sum of 2 quarters · filed 2026-08-06 | $119.48M 10-Q · filed 2025-10-28 | $19.22M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.11M 10-Q · filed 2026-08-06 | -$97.15M derived: sum of 3 quarters · filed 2026-08-06 | $25.13M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$2.65M 10-Q · filed 2026-05-05 | -$102.91M derived: sum of 2 quarters · filed 2026-05-05 | $19.37M derived: sum of 3 quarters · filed 2026-05-05 | $24.11M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$100.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.02M derived: sum of 2 quarters · filed 2026-02-26 | $26.77M derived: sum of 3 quarters · filed 2026-02-26 | -$32.24M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $122.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $127.03M derived: sum of 2 quarters · filed 2025-10-28 | $68.02M 10-Q · filed 2025-10-28 | $80.54M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $4.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$54.26M 10-Q · filed 2025-08-05 | -$41.74M derived: sum of 3 quarters · filed 2026-02-26 | $39.69M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$59.01M 10-Q · filed 2025-05-02 | -$46.49M derived: sum of 2 quarters · filed 2026-02-26 | $34.94M derived: sum of 3 quarters · filed 2026-02-26 | $41.53M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $12.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $93.95M derived: sum of 2 quarters · filed 2026-02-26 | $100.54M derived: sum of 3 quarters · filed 2026-02-26 | $68.85M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $81.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $88.02M derived: sum of 2 quarters · filed 2024-10-31 | $56.33M 10-Q · filed 2024-10-31 | $117.75M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-06-30 | $6.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$25.09M 10-Q · filed 2024-08-05 | $36.32M derived: sum of 3 quarters · filed 2025-02-24 | $110.27M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-03-31 | -$31.69M 10-Q · filed 2024-04-26 | $29.73M derived: sum of 2 quarters · filed 2025-02-24 | $103.68M derived: sum of 3 quarters · filed 2025-02-24 | $105.47M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-12-31 | $61.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $135.36M derived: sum of 2 quarters · filed 2025-02-24 | $137.16M derived: sum of 3 quarters · filed 2025-02-24 | $59.02M 10-K · filed 2025-02-24 | ||||
| 2022-09-30 | $73.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $75.75M derived: sum of 2 quarters · filed 2023-11-02 | -$2.40M 10-Q · filed 2023-11-02 | $20.42M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$76.34M 10-Q · filed 2023-08-02 | -$53.53M derived: sum of 3 quarters · filed 2024-02-26 | $228.00K derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | -$78.14M 10-Q · filed 2023-04-28 | -$55.33M derived: sum of 2 quarters · filed 2024-02-26 | -$1.57M derived: sum of 3 quarters · filed 2024-02-26 | $9.85M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $22.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $76.57M derived: sum of 2 quarters · filed 2024-02-26 | $87.99M derived: sum of 3 quarters · filed 2024-02-26 | $15.69M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $53.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $65.17M derived: sum of 2 quarters · filed 2022-10-28 | -$7.13M 10-Q · filed 2022-10-28 | -$17.98M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $11.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$60.88M 10-Q · filed 2022-08-04 | -$71.73M derived: sum of 3 quarters · filed 2023-02-27 | -$53.48M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$72.30M 10-Q · filed 2022-04-29 | -$83.16M derived: sum of 2 quarters · filed 2023-02-27 | -$64.90M derived: sum of 3 quarters · filed 2023-02-27 | -$64.60M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$10.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $7.40M derived: sum of 2 quarters · filed 2023-02-27 | $7.71M derived: sum of 3 quarters · filed 2023-02-27 | -$87.03M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $18.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $18.56M derived: sum of 2 quarters · filed 2021-10-29 | -$76.17M 10-Q · filed 2021-10-29 | -$20.83M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $308.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$94.42M 10-Q · filed 2021-07-30 | -$39.08M derived: sum of 3 quarters · filed 2022-02-25 | $20.23M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | -$94.73M 10-Q · filed 2021-04-30 | -$39.39M derived: sum of 2 quarters · filed 2022-02-25 | $19.93M derived: sum of 3 quarters · filed 2022-02-25 | $24.43M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $55.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $114.66M derived: sum of 2 quarters · filed 2022-02-25 | $119.16M derived: sum of 3 quarters · filed 2022-02-25 | $77.09M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $59.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $63.82M derived: sum of 2 quarters · filed 2020-11-06 | $21.75M 10-Q · filed 2020-11-06 | $72.23M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$37.57M 10-Q · filed 2020-08-05 | $12.91M derived: sum of 3 quarters · filed 2021-02-26 | $33.81M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | -$42.07M 10-Q · filed 2020-05-01 | $8.41M derived: sum of 2 quarters · filed 2021-02-26 | $29.31M derived: sum of 3 quarters · filed 2021-02-26 | $48.21M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $50.48M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $71.38M derived: sum of 2 quarters · filed 2021-02-26 | $90.28M derived: sum of 3 quarters · filed 2021-02-26 | $38.39M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $20.90M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | $39.80M derived: sum of 2 quarters · filed 2019-11-04 | -$12.09M 10-Q/A · filed 2019-11-04 | $35.16M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $18.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$32.99M 10-Q · filed 2019-08-02 | $14.26M derived: sum of 3 quarters · filed 2020-02-27 | $48.81M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$51.89M 10-Q · filed 2019-04-29 | -$4.64M derived: sum of 2 quarters · filed 2020-02-27 | $29.92M derived: sum of 3 quarters · filed 2020-02-27 | $71.45M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $47.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $81.80M derived: sum of 2 quarters · filed 2020-02-27 | $123.34M derived: sum of 3 quarters · filed 2020-02-27 | $45.52M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $34.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $76.09M derived: sum of 2 quarters · filed 2018-10-26 | -$1.73M 10-Q · filed 2018-10-26 | $22.91M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $41.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$36.29M 10-Q · filed 2018-08-03 | -$11.64M derived: sum of 3 quarters · filed 2019-02-28 | -$1.93M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$77.82M 10-Q · filed 2018-04-27 | -$53.17M derived: sum of 2 quarters · filed 2019-02-28 | -$43.47M derived: sum of 3 quarters · filed 2019-02-28 | -$40.28M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $24.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $34.35M derived: sum of 2 quarters · filed 2019-02-28 | $37.54M derived: sum of 3 quarters · filed 2019-02-28 | -$53.20M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $9.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $12.89M derived: sum of 2 quarters · filed 2017-10-31 | -$77.85M 10-Q · filed 2017-10-31 | $11.52M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$87.56M 10-Q · filed 2017-08-02 | $1.81M derived: sum of 3 quarters · filed 2018-02-26 | $36.37M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | -$90.74M 10-Q · filed 2017-05-04 | -$1.37M derived: sum of 2 quarters · filed 2018-02-26 | $33.19M derived: sum of 3 quarters · filed 2018-02-26 | $56.79M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $89.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $123.93M derived: sum of 2 quarters · filed 2018-02-26 | $147.53M derived: sum of 3 quarters · filed 2018-02-26 | $90.30M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $34.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $58.16M derived: sum of 2 quarters · filed 2016-11-03 | $924.00K 10-Q · filed 2016-11-03 | $8.03M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $23.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$33.63M 10-Q · filed 2016-08-08 | -$26.52M derived: sum of 3 quarters · filed 2017-02-27 | $10.48M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | -$57.24M 10-Q · filed 2016-05-02 | -$50.13M derived: sum of 2 quarters · filed 2017-02-27 | -$13.12M derived: sum of 3 quarters · filed 2017-02-27 | -$176.00K derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $44.11M derived: sum of 2 quarters · filed 2017-02-27 | $57.06M derived: sum of 3 quarters · filed 2017-02-27 | $38.04M 10-K · filed 2017-02-27 | $38.71M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $49.95M derived: sum of 2 quarters · filed 2015-11-02 | $30.93M 10-Q · filed 2015-11-02 | $31.49M 10-Q · filed 2014-10-28 | $39.87M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $12.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$6.07M 10-Q · filed 2015-08-05 | -$5.95M 10-Q · filed 2014-07-31 | $2.87M derived: sum of 3 quarters · filed 2016-02-29 | $21.93M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$19.02M 10-Q · filed 2015-05-05 | -$18.92M 10-Q · filed 2014-05-02 | -$10.08M derived: sum of 2 quarters · filed 2016-02-29 | $8.98M derived: sum of 3 quarters · filed 2016-02-29 | $8.02M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $28.00M derived: sum of 2 quarters · filed 2016-02-29 | $27.04M derived: sum of 3 quarters · filed 2016-02-29 | $20.30M 10-K · filed 2016-02-29 | $20.42M 10-K · filed 2014-02-26 | |||
| 2013-09-30 | $19.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $18.09M derived: sum of 2 quarters · filed 2014-10-28 | $11.36M 10-Q · filed 2014-10-28 | $32.95M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$963.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$7.70M 10-Q · filed 2014-07-31 | $13.89M derived: sum of 3 quarters · filed 2015-03-02 | $28.28M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | -$6.73M 10-Q · filed 2014-05-02 | $14.85M derived: sum of 2 quarters · filed 2015-03-02 | $29.25M derived: sum of 3 quarters · filed 2015-03-02 | $26.85M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $21.59M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $35.98M derived: sum of 2 quarters · filed 2015-03-02 | $33.59M derived: sum of 3 quarters · filed 2015-03-02 | $37.41M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $14.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $12.00M derived: sum of 2 quarters · filed 2013-10-28 | $15.82M 10-Q · filed 2013-10-28 | $24.14M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | -$2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $1.43M 10-Q · filed 2013-07-29 | $9.74M derived: sum of 3 quarters · filed 2014-02-26 | $13.89M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $3.83M 10-Q · filed 2013-04-29 | $12.14M derived: sum of 2 quarters · filed 2014-02-26 | $16.28M derived: sum of 3 quarters · filed 2014-02-26 | $15.80M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $12.46M derived: sum of 2 quarters · filed 2014-02-26 | $11.97M derived: sum of 3 quarters · filed 2014-02-26 | $9.77M 10-K · filed 2014-02-26 | $10.11M 10-K · filed 2012-02-22 | |||
| 2011-09-30 | $4.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $3.66M derived: sum of 2 quarters · filed 2012-10-29 | $1.46M 10-Q · filed 2012-10-29 | -$693.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | -$483.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$2.69M 10-Q · filed 2012-08-02 | -$4.84M derived: sum of 3 quarters · filed 2013-02-26 | -$2.27M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | -$2.20M 10-Q · filed 2012-04-30 | -$4.36M derived: sum of 2 quarters · filed 2013-02-26 | -$1.79M derived: sum of 3 quarters · filed 2013-02-26 | $6.37M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $413.00K derived: sum of 2 quarters · filed 2013-02-26 | $8.58M derived: sum of 3 quarters · filed 2013-02-26 | $2.17M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $10.73M derived: sum of 2 quarters · filed 2011-10-31 | $4.32M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $8.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $1.75M 10-Q · filed 2011-08-01 | ||||||
| 2010-03-31 | -$6.41M 10-Q · filed 2011-04-29 | |||||||
| 2009-12-31 | $7.80M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |